Prevalence Trends of Anemia Impairment in Adolescents and Young Adults with HIV/AIDS

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2024 May 13

PMID 38741063

Authors

Xinqi Li

Nan Zhang

Linlu Ma

Qian Wang

Yuxing Liang

Xiaoyan Liu

Fuling Zhou

Affiliations

Soon will be listed here.

Abstract

Background: Anemia is a common complication of HIV/AIDS, particularly in adolescents and young adults across various countries and regions. However, little is known about the changing prevalence trends of anemia impairment in this population over time.

Methods: Data on anemia in adolescents and young adults with HIV/AIDS from 1990 to 2019 were collected from the Global Burden of Disease. Prevalence was calculated by gender, region, and country for individuals aged 10-24, and trends were measured using estimating annual percentage changes (EAPC).

Results: Globally, the prevalence of adolescents and young adults with HIV/AIDS increased from 103.95 per 100,000 population in 1990 to 203.78 in 2019. However, anemia impairment has decreased over the past three decades, with a global percentage decreasing from 70.6% in 1990 to 34.7% in 2019, mainly presenting as mild to moderate anemia and significantly higher in females than males. The largest decreases were observed in Central Sub-Saharan Africa, North America, and Eastern Sub-Saharan Africa, with EAPCs of -2.8, -2.34, and -2.17, respectively. Tajikistan (78.76%) and Madagascar (74.65%) had the highest anemia impairment percentage in 2019, while China (16.61%) and Iceland (13.73%) had the lowest. Anemia impairment was closely related to sociodemographic index (SDI) levels, with a high proportion of impairment in low SDI regions but a stable decreasing trend (EAPC = -0.37).

Conclusion: Continued anemia monitoring and management are crucial for patients with HIV, especially in high-prevalence regions and among females. Public health policies and interventions can improve the quality of life and reduce morbidity and mortality.

Citing Articles

Severe anaemia in people with HIV: demographic, clinical and renal correlates.

Kamvuma K, Munsaka S, Masenga S, Mulemena J, Phiri C, Miyoba M BMC Res Notes. 2025; 18(1):51.

PMID: 39901231 PMC: 11792207. DOI: 10.1186/s13104-025-07100-x.

Prevalence and factors associated with moderate-to-severe anaemia among virally suppressed people with HIV at a tertiary hospital in Zambia.

Kamvuma K, Masenga S, Hamooya B, Chanda W, Munsaka S PLoS One. 2024; 19(8):e0303734.

PMID: 39186572 PMC: 11346727. DOI: 10.1371/journal.pone.0303734.

Prevalence trends of anemia impairment in adolescents and young adults with HIV/AIDS.

Li X, Zhang N, Ma L, Wang Q, Liang Y, Liu X BMC Public Health. 2024; 24(1):1301.

PMID: 38741063 PMC: 11092044. DOI: 10.1186/s12889-024-18730-4.

References

Nachega J, Scarsi K, Gandhi M, Scott R, Mofenson L, Archary M . Long-acting antiretrovirals and HIV treatment adherence. Lancet HIV. 2023; 10(5):e332-e342. PMC: 10734401. DOI: 10.1016/S2352-3018(23)00051-6. View

Assefa Y, Gilks C . Ending the epidemic of HIV/AIDS by 2030: Will there be an endgame to HIV, or an endemic HIV requiring an integrated health systems response in many countries?. Int J Infect Dis. 2020; 100:273-277. DOI: 10.1016/j.ijid.2020.09.011. View

Zhang J, Ma B, Han X, Ding S, Li Y . Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10-24 years from 1990 to 2019: a trend analysis based on the Global Burden of Disease Study 2019. Lancet Child Adolesc Health. 2022; 6(11):763-776. DOI: 10.1016/S2352-4642(22)00219-X. View

Mei Z, Addo O, Jefferds M, Sharma A, Flores-Ayala R, Brittenham G . Physiologically based serum ferritin thresholds for iron deficiency in children and non-pregnant women: a US National Health and Nutrition Examination Surveys (NHANES) serial cross-sectional study. Lancet Haematol. 2021; 8(8):e572-e582. PMC: 8948503. DOI: 10.1016/S2352-3026(21)00168-X. View

Massetti G, Stamatakis C, Charania S, Annor F, Rice C, Hegle J . Prevalence of Functional Disabilities and Associations Among Disabilities, Violence, and HIV Among Adolescents and Young Adults in Lesotho. J Epidemiol Glob Health. 2024; 14(1):223-233. PMC: 11043310. DOI: 10.1007/s44197-023-00184-3. View

. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022; 9(2):137-150. PMC: 8776563. DOI: 10.1016/S2215-0366(21)00395-3. View

Hankey B, Ries L, Kosary C, Feuer E, Merrill R, Clegg L . Partitioning linear trends in age-adjusted rates. Cancer Causes Control. 2000; 11(1):31-5. DOI: 10.1023/a:1008953201688. View

Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G . Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023; 13(1):82. PMC: 10188596. DOI: 10.1038/s41408-023-00853-3. View

Ara Jo-Pereira M, Sheikh V, Sereti I, Barreto-Duarte B, Arriaga M, Tib Rcio R . Association between severe anaemia and inflammation, risk of IRIS and death in persons with HIV: A multinational cohort study. EBioMedicine. 2022; 85:104309. PMC: 9593179. DOI: 10.1016/j.ebiom.2022.104309. View

10.

. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 385(9963):117-71. PMC: 4340604. DOI: 10.1016/S0140-6736(14)61682-2. View

11.

Cao G, Liu J, Liu M . Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019. JAMA Pediatr. 2022; 176(8):787-796. PMC: 9157382. DOI: 10.1001/jamapediatrics.2022.1622. View

12.

Aung P, Han K, Groot W, Biesma R, Thein Z, Htay T . Heterogeneity in the prevalence of subclinical malaria, other co-infections and anemia among pregnant women in rural areas of Myanmar: a community-based longitudinal study. Trop Med Health. 2024; 52(1):22. PMC: 10921590. DOI: 10.1186/s41182-024-00577-5. View

13.

Uetela D, Augusto O, Hughes J, Uetela O, Gudo E, Chicumbe S . Impact of differentiated service delivery models on 12-month retention in HIV treatment in Mozambique: an interrupted time-series analysis. Lancet HIV. 2023; 10(10):e674-e683. DOI: 10.1016/S2352-3018(23)00184-4. View

14.

Owais A, Merritt C, Lee C, Bhutta Z . Anemia among Women of Reproductive Age: An Overview of Global Burden, Trends, Determinants, and Drivers of Progress in Low- and Middle-Income Countries. Nutrients. 2021; 13(8). PMC: 8401240. DOI: 10.3390/nu13082745. View

15.

Demitto F, Araujo-Pereira M, Schmaltz C, SantAnna F, Arriaga M, Andrade B . Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV. Front Immunol. 2020; 11:588405. PMC: 7541849. DOI: 10.3389/fimmu.2020.588405. View

16.

Mwirigi A, Stockwell S, Radia D, Kulasegaram R, Kesse-Adu R . Immune reconstitution inflammatory syndrome in a patient with HIV presenting as severe mixed haemolytic anaemia. Int J STD AIDS. 2015; 27(11):1019-22. DOI: 10.1177/0956462415611521. View

17.

Ezeamama A, Sikorskii A, Bajwa R, Tuke R, Kyeyune R, Fenton J . Evolution of Anemia Types During Antiretroviral Therapy-Implications for Treatment Outcomes and Quality of Life Among HIV-Infected Adults. Nutrients. 2019; 11(4). PMC: 6521252. DOI: 10.3390/nu11040755. View

18.

Cao G, Wang Y, Wu Y, Jing W, Liu J, Liu M . Prevalence of anemia among people living with HIV: A systematic review and meta-analysis. EClinicalMedicine. 2022; 44:101283. PMC: 8803600. DOI: 10.1016/j.eclinm.2022.101283. View

19.

Safiri S, Kolahi A, Noori M, Nejadghaderi S, Karamzad N, Bragazzi N . Burden of anemia and its underlying causes in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. J Hematol Oncol. 2021; 14(1):185. PMC: 8567696. DOI: 10.1186/s13045-021-01202-2. View

20.

. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Glob Health. 2022; 10(12):e1715-e1743. PMC: 9666426. DOI: 10.1016/S2214-109X(22)00429-6. View